This company listing is no longer active
EVE Stock Overview
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Evolva Holding SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 1.01 |
| 52 Week High | CHF 19.00 |
| 52 Week Low | CHF 0.62 |
| Beta | 0.20 |
| 1 Month Change | 1.00% |
| 3 Month Change | 48.53% |
| 1 Year Change | -94.67% |
| 3 Year Change | -97.88% |
| 5 Year Change | -98.21% |
| Change since IPO | -99.68% |
Recent News & Updates
Recent updates
We Think Evolva Holding (VTX:EVE) Has A Fair Chunk Of Debt
Nov 21
Would Evolva Holding (VTX:EVE) Be Better Off With Less Debt?
Jun 09Evolva Holding SA (VTX:EVE) Screens Well But There Might Be A Catch
May 05Is Evolva Holding (VTX:EVE) Using Debt In A Risky Way?
Mar 22Is Evolva Holding (VTX:EVE) Weighed On By Its Debt Load?
Dec 01Shareholders Will Probably Hold Off On Increasing Evolva Holding SA's (VTX:EVE) CEO Compensation For The Time Being
Apr 01Evolva Holding's (VTX:EVE) Shareholders Are Down 70% On Their Shares
Feb 13We're Keeping An Eye On Evolva Holding's (VTX:EVE) Cash Burn Rate
Dec 21
Shareholder Returns
| EVE | CH Chemicals | CH Market | |
|---|---|---|---|
| 7D | 7.2% | -0.5% | -1.1% |
| 1Y | -94.7% | -0.6% | 3.1% |
Return vs Industry: EVE underperformed the Swiss Chemicals industry which returned 10.6% over the past year.
Return vs Market: EVE underperformed the Swiss Market which returned -3.3% over the past year.
Price Volatility
| EVE volatility | |
|---|---|
| EVE Average Weekly Movement | 17.8% |
| Chemicals Industry Average Movement | 2.6% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 8.1% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: EVE's share price has been volatile over the past 3 months.
Volatility Over Time: EVE's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 49 | n/a | www.evolva.com |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Evolva Holding SA Fundamentals Summary
| EVE fundamental statistics | |
|---|---|
| Market cap | CHF 7.28m |
| Earnings (TTM) | -CHF 101.22m |
| Revenue (TTM) | CHF 4.16m |
1.8x
P/S Ratio-0.1x
P/E RatioIs EVE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVE income statement (TTM) | |
|---|---|
| Revenue | CHF 4.16m |
| Cost of Revenue | CHF 0 |
| Gross Profit | CHF 4.16m |
| Other Expenses | CHF 105.37m |
| Earnings | -CHF 101.22m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -14.04 |
| Gross Margin | 100.00% |
| Net Profit Margin | -2,434.99% |
| Debt/Equity Ratio | 0% |
How did EVE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/26 09:28 |
| End of Day Share Price | 2024/04/26 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Evolva Holding SA is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marta Bruska | Bank am Bellevue |
| Sebastian Bray | Berenberg |
| Christoph Gretler | Credit Suisse |